[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial (2026) Ferone D, Pavel ME, Herrmann K, Kunz PL, Myrehaug S, Halperin D, Chasen B, et al. Journal article Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial (2025) Poryo M, Gortner L, Bay J, Franz AR, Ehrhardt H, Klein L, Behnke J, et al. Journal article An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease (2025) Solitano V, Hanžel J, Ma C, Battat R, Raine T, Siegmund B, Peyrin-Biroulet L, et al. Journal article Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT) (2025) Hohberger B, Ganslmayer M, Harrer T, Kruse F, Maas S, Borst T, Heimke-Brinck R, et al. Journal article Corrigendum to “Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial” (2025) Poryo M, Gortner L, Bay J, Franz AR, Ehrhardt H, Klein L, Behnke J, et al. Journal article, Erratum A multimodal aftercare intervention improves the outcome after kidney transplantation – results of the KTx360° aftercare program using claims data (2024) Pape L, DeZwaan M, Nöhre M, Klewitz F, Kyaw Tha Tun E, Prüfe J, Schiffer L, et al. Journal article Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program (2024) Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, et al. Journal article Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. (2024) Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, et al. Journal article, Review article Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study) (2024) Stumpf J, Budde K, Witzke O, Sommerer C, Vogel T, Schenker P, Woitas RP, et al. Journal article Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study. (2023) Dagliati A, Strasser ZH, Hossein Abad ZS, Klann JG, Wagholikar KB, Mesa R, Visweswaran S, et al. Journal article